Free Trial

Capital Fund Management S.A. Buys Shares of 45,719 Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background

Key Points

  • Capital Fund Management S.A. acquired 45,719 shares of Synopsys, Inc., valued at approximately $19.6 million, during the 1st quarter, reflecting increased institutional interest in the company.
  • Several analysts raised their price targets for Synopsys, with Piper Sandler setting a new target at $660 and a consensus rating of "Moderate Buy" from 13 analysts.
  • Synopsys reported $3.67 EPS for the last quarter, exceeding expectations, with a year-over-year revenue increase of 10.3% compared to the previous year's same period.
  • Want stock alerts on Synopsys? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Capital Fund Management S.A. acquired a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 45,719 shares of the semiconductor company's stock, valued at approximately $19,607,000.

Several other large investors also recently bought and sold shares of the company. Williams Jones Wealth Management LLC. grew its position in Synopsys by 0.5% in the fourth quarter. Williams Jones Wealth Management LLC. now owns 4,650 shares of the semiconductor company's stock valued at $2,257,000 after acquiring an additional 22 shares in the last quarter. Hardy Reed LLC boosted its stake in shares of Synopsys by 0.7% during the 1st quarter. Hardy Reed LLC now owns 3,290 shares of the semiconductor company's stock valued at $1,411,000 after buying an additional 22 shares during the last quarter. Resurgent Financial Advisors LLC boosted its stake in shares of Synopsys by 2.7% during the 1st quarter. Resurgent Financial Advisors LLC now owns 832 shares of the semiconductor company's stock valued at $357,000 after buying an additional 22 shares during the last quarter. Trust Asset Management LLC boosted its stake in shares of Synopsys by 1.3% during the 1st quarter. Trust Asset Management LLC now owns 1,766 shares of the semiconductor company's stock valued at $757,000 after buying an additional 22 shares during the last quarter. Finally, Argent Trust Co boosted its stake in shares of Synopsys by 2.8% during the 1st quarter. Argent Trust Co now owns 856 shares of the semiconductor company's stock valued at $367,000 after buying an additional 23 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.

Synopsys Stock Performance

SNPS traded down $8.4440 during trading hours on Monday, hitting $598.0760. 490,444 shares of the stock were exchanged, compared to its average volume of 1,415,592. The stock has a 50-day simple moving average of $570.29 and a 200-day simple moving average of $500.54. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The stock has a market cap of $92.80 billion, a price-to-earnings ratio of 43.14, a price-to-earnings-growth ratio of 3.99 and a beta of 1.15. The company has a debt-to-equity ratio of 1.01, a current ratio of 7.02 and a quick ratio of 6.85.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.40 by $0.27. Synopsys had a return on equity of 17.09% and a net margin of 34.77%.The firm had revenue of $1.60 billion for the quarter, compared to analysts' expectations of $1.60 billion. During the same period last year, the business posted $3.00 earnings per share. The firm's revenue for the quarter was up 10.3% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. Analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Wall Street Analyst Weigh In

SNPS has been the subject of several research analyst reports. Piper Sandler increased their target price on Synopsys from $615.00 to $660.00 and gave the company an "overweight" rating in a research note on Monday, July 21st. Morgan Stanley reiterated an "overweight" rating and set a $715.00 target price (up from $540.00) on shares of Synopsys in a research note on Monday, August 11th. KeyCorp increased their target price on Synopsys from $540.00 to $610.00 and gave the company an "overweight" rating in a research note on Thursday, July 10th. The Goldman Sachs Group initiated coverage on Synopsys in a research note on Thursday, July 10th. They set a "buy" rating and a $620.00 target price for the company. Finally, Bank of America increased their target price on Synopsys from $575.00 to $625.00 and gave the company a "buy" rating in a research note on Wednesday, July 16th. Twelve analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $626.79.

Check Out Our Latest Analysis on Synopsys

Insider Buying and Selling at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 7,310 shares of the firm's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $485.72, for a total value of $3,550,613.20. Following the sale, the chief financial officer directly owned 15,291 shares in the company, valued at approximately $7,427,144.52. This trade represents a 32.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CRO Richard S. Mahoney sold 9,010 shares of the firm's stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total value of $4,245,602.10. Following the completion of the sale, the executive owned 1,485 shares in the company, valued at $699,746.85. The trade was a 85.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 27,686 shares of company stock worth $13,001,048. 0.62% of the stock is owned by insiders.

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market
Next Tech Boom: AI Robots Are Coming Sooner Than You Think!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines